+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton beam therapy for the management of mediastinal Hodgkin lymphoma in a young female patient



Proton beam therapy for the management of mediastinal Hodgkin lymphoma in a young female patient



Cancer Radiotherapie 22(3): 296-298




(PDF emailed within 0-6 h: $19.90)

Accession: 065445432

Download citation: RISBibTeXText

PMID: 29606542

DOI: 10.1016/j.canrad.2017.09.009


Related references

Severe left main coronary stenosis in a young female patient, 6 years after mediastinal radiation therapy for non-Hodgkin lymphoma: assessment by coronary angiography and intravascular ultrasound. Clinical Research in Cardiology 101(4): 317-320, 2012

Dosimetric advantages of a "butterfly" technique for intensity-modulated radiation therapy for young female patients with mediastinal Hodgkin's lymphoma. Radiation Oncology 9: 94, 2015

Comparison of passive-beam proton therapy, helical tomotherapy and 3D conformal radiation therapy in Hodgkin's lymphoma female patients receiving involved-field or involved site radiation therapy. Cancer Radiotherapie 20(2): 98-103, 2016

Intensity Modulated Radiation Therapy (IMRT) Using Butterfly Technique Offers a Dosimetric Advantage to Critical Organs in Young Female Patients With Mediastinal Hodgkin Lymphoma. International Journal of Radiation Oncology*biology*physics 87(2): S163-S164, 2013

Rationale for and preliminary results of proton beam therapy for mediastinal lymphoma. International Journal of Radiation Oncology, Biology, Physics 81(1): 167-174, 2011

Proton therapy in mediastinal Hodgkin lymphoma: moving from dosimetric prediction to clinical evidence. Annals of Oncology 28(9): 2049-2050, 2017

The Impact of IMRT and Proton Beam Therapy on Overall Survival for Patients With Hodgkin Lymphoma. International Journal of Radiation Oncology*biology*physics 93(3): S80-S81, 2015

Late cardiac effect of radiation therapy on a young woman with mediastinal Hodgkin's lymphoma. General Thoracic and Cardiovascular Surgery 64(1): 51-54, 2016

Consolidative involved-node proton therapy for Stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a Phase II study. International Journal of Radiation Oncology, Biology, Physics 83(1): 260-267, 2012

Proton therapy in the management of non-Hodgkin lymphoma. Leukemia and Lymphoma 56(9): 2608-2612, 2016

Proton therapy in a pediatric patient with stage III Hodgkin lymphoma. Acta Oncologica 52(3): 592-594, 2013

Comparative treatment planning study for mediastinal Hodgkin's lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy. Acta Oncologica 2018: 1-10, 2018

Noncoplanar intensity-modulated radiation therapy for young female patients with mediastinal lymphoma. Journal of Applied Clinical Medical Physics 13(6): 3769, 2013

Novel regimens prior to autologous stem cell transplantation for the management of adults with relapsed/refractory non-Hodgkin lymphoma and Hodgkin lymphoma: alternatives to BEAM conditioning. Leukemia and Lymphoma 57(11): 2499-2509, 2017

Proton therapy to the subdiaphragmatic region in the management of patients with Hodgkin lymphoma. Leukemia and Lymphoma 56(7): 2019-2024, 2016